Mode
Text Size
Log in / Sign up

Long-term particulate matter exposure increases risk of Parkinson's disease by 10% to 18%Long term air pollution exposure linked to Parkinson's disease risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that long-term exposure to particulate matter is associated with an increased risk of Parkinson's disease.

This meta-analysis synthesizes data on the impact of long-term (greater than or equal to 1 year) outdoor air pollution exposure, specifically Particulate Matter 2.5 (PM) and nitrogen dioxide (NO), on the incidence of Parkinson's disease, multiple sclerosis, and motor neuron diseases in adults.

The analysis found that every 5 μg/m increase of PM is associated with a 10% increased risk of Parkinson's disease (95% CI: 1.03-1.19). For an increase of 15 μg/m, the risk was 18% (95% CI: 1.01-1.38), with the largest estimated risk observed for PM in Asia (95% CI: 1.01-1.41). However, no clear evidence of association was found between PM or NO and multiple sclerosis, nor was an association observed between PM and motor neuron disease.

The authors note that the evidence base for both multiple sclerosis and motor neuron diseases is very limited. Furthermore, results regarding Parkinson's disease vary across settings, as indicated by a prediction interval of 0.80-1.52 for PM. These findings suggest an association between air pollution and Parkinson's disease, but clinical application remains cautious due to the variability in geographical data.

How this fits prior evidence

This meta-analysis addresses gaps in understanding environmental risk factors for neurodegenerative conditions. It adds to existing evidence regarding Parkinson's disease, which has been previously explored through interventions like fecal microbiota transplantation and mindfulness-based exercise. While this study identifies a specific association between particulate matter and Parkinson's disease risk, it does not provide new data on the management of multiple sclerosis or motor neuron diseases.

Breathing in polluted air for years might do more than just irritate your lungs. New data suggests a link between long-term exposure to outdoor pollutants and the development of Parkinson's disease, a condition that affects movement and coordination.

The analysis looked at how particulate matter (small particles in the air) and nitrogen dioxide impact health over time. For every 5 micrograms per cubic meter increase in particulate matter, the risk of Parkinson's disease rose by 10 percent. This risk was even higher in Asia, where researchers found the largest estimated risk for the condition.

While the link to Parkinson's is clear, the evidence for other conditions like multiple sclerosis and motor neuron diseases is currently very limited. Because of this small amount of data, no clear connection was found between air pollution and those specific diseases. Results can also vary depending on the setting, so these findings highlight a specific concern regarding Parkinson's disease.

What this means for you:
Long-term exposure to particulate matter in outdoor air is linked to an increased risk of Parkinson's disease.

Common questions

What kind of air pollution was linked to Parkinson's?

The study looked at long-term exposure (at least one year) to outdoor air pollution, specifically particulate matter (PM) and nitrogen dioxide (NO). The data showed that as levels of particulate matter increased, the risk of developing Parkinson's disease also went up.

Is there a link between air pollution and multiple sclerosis?

The study did not find clear evidence of an association between air pollution and multiple sclerosis. However, researchers noted that the evidence base for this specific condition was very limited, making it hard to draw firm conclusions.

How much does particulate matter increase Parkinson's risk?

For every 5 micrograms per cubic meter increase in particulate matter, there was a 10 percent increased risk of Parkinson's disease. For a larger increase of 15 micrograms per cubic meter, the risk rose by 18 percent.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up12.0 mo
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Parkinson's disease (PD), multiple sclerosis (MS) and motor neurone disease (MND) are progressive and debilitating diseases that are increasing in prevalence globally. Some primary studies show an increased risk from long-term outdoor air pollution exposure, while others contradict this association. METHODS: A systematic review and meta-analysis were undertaken to assess the associations of long-term (≥1 year) outdoor air pollution exposure with PD, MS and MND incidence. We searched eight databases for publications up to July 2025. Primary case-control, cohort, cross-sectional or ecological studies investigating the association between long-term air pollution exposure and adult (>18 years old) PD, MS, or MND incidence were included. Meta-analyses were carried out using random-effects models with assessment of heterogeneity, meta-bias and shape of the exposure-response functions. PROSPERO (CRD42023417961). RESULTS: Of 42 papers included, 26, 3 and 3 were meta-analysed for PD, MS, and MND outcomes, respectively. 19 studies from North America, 12 from Europe and 10 from Asia were meta-analysed. For every 5 μg/m and 15 μg/m increase of Particulate Matter 2.5 (PM) and PM concentration, estimated (95% Confidence Interval) PD risk was 10% (1.10; 1.03-1.19) and 18% (1.18; 1.01-1.38), respectively but effects varied across settings (Prediction Interval: 0.80-1.52 for PM and 0.41-3.36 for PM), with the largest estimated risk for PM in Asia (1.19; 1.01-1.41). There was no clear evidence that PM (1.01; 0.77-1.32) or nitrogen dioxide (NO, 0.98, 95% CI: 0.95-1.01) were associated with MS risk or PM with MND risk (1.07, 95% CI: 0.86-1.33). CONCLUSION: This systematic review reports increased PD risk from long-term PM and PM exposure. No association was observed for MS and MND from a very limited evidence base. The neurodegenerative diseases investigated here are rare and therefore alternatives to insufficiently powered cohort studies are needed to strengthen the evidence on risk.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.